BioNexus Gene Lab Corp. (BGLC)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$2.07
-4.61%
Mkt Cap $4.02M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 14, 2026 | — | $483.76K | — | — | -$0.52 | — | — | — |
| Q4 2025 Nov 14, 2025 | — | $2.54M | — | — | -$0.39 | — | — | — |
| Q3 2025 Aug 18, 2025 | — | $2.26M | — | — | -$0.34 | — | — | — |
| Q2 2025 May 15, 2025 | — | $2.14M | — | — | -$0.03 | — | — | — |
| Q2 2025 Apr 15, 2025 | — | $2.52M | — | — | -$0.19 | — | — | — |
| Q4 2024 Nov 15, 2024 | — | $2.63M | — | — | -$0.20 | — | — | — |
| Q3 2024 Aug 14, 2024 | — | $1.97M | — | — | $0.10 | — | — | — |
| Q2 2024 May 31, 2024 | — | $2.57M | — | — | -$0.18 | — | — | — |
| Q2 2024 May 15, 2024 | — | $2.38M | — | — | -$0.18 | — | — | — |
| Q1 2024 Mar 29, 2024 | — | $2.27M | — | — | $0.17 | — | — | — |
| Q4 2023 Nov 20, 2023 | — | $2.55M | — | — | -$0.20 | — | — | — |
| Q4 2022 Nov 14, 2022 | — | $2.58M | — | — | -$0.05 | — | — | — |
| Q3 2022 Aug 15, 2022 | — | $2.49M | — | — | -$0.10 | — | — | — |
| Q2 2022 May 16, 2022 | — | $3.03M | — | — | $0.01 | — | — | — |
| Q2 2022 Apr 6, 2022 | — | $3.25M | — | — | $0.06 | — | — | — |
| Q4 2021 Nov 15, 2021 | — | $3.58M | — | — | $0.21 | — | — | — |
| Q3 2021 Aug 12, 2021 | — | $3.09M | — | — | $0.02 | — | — | — |
| Q2 2021 May 18, 2021 | — | $3.45M | — | — | $0.24 | — | — | — |
| Q1 2021 Mar 30, 2021 | — | $11.36M | — | — | $1.47 | — | — | — |
| Q4 2020 Nov 3, 2020 | — | $23.47K | — | — | $0.27 | — | — | — |